Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-7-27
pubmed:abstractText
Allergic diseases represent a major health problem in Europe. They are increasing in prevalence, severity and costs. The Global Allergy and Asthma European Network (GA(2)LEN), a Sixth EU Framework Program for Research and Technological Development (FP6) Network of Excellence, was created in 2005 as a vehicle to ensure excellence in research bringing together research and clinical institutions to combat fragmentation in the European research area and to tackle allergy in its globality. The Global Allergy and Asthma European Network has benefited greatly from the voluntary efforts of researchers who are strongly committed to this model of pan-European collaboration. The network was organized in order to increase networking for scientific projects in allergy and asthma around Europe and to make GA(2)LEN the world leader in the field. Besides these activities, research has also been carried out and the first papers are being published. Achievements of the Global Allergy and Asthma European Network can be grouped as follows: (i) those for a durable infrastructure built up during the project phase, (ii) those which are project-related and based on these novel infrastructures, and (iii) the development and implementation of guidelines. The major achievements of GA(2)LEN are reported in this paper.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1398-9995
pubmed:author
pubmed-author:AkdisC ACA, pubmed-author:AntoJJ, pubmed-author:AuvergneNN, pubmed-author:BachertCC, pubmed-author:Bindslev-JensenCC, pubmed-author:BoniniSS, pubmed-author:BousquetJJ, pubmed-author:BousquetP JPJ, pubmed-author:BrunekreefBB, pubmed-author:BurneyP GPG, pubmed-author:CanonicaG WGW, pubmed-author:CarlsenK HKH, pubmed-author:CauwenbergeP VPV, pubmed-author:FokkensW JWJ, pubmed-author:GjomarkajMM, pubmed-author:HaahtelaTT, pubmed-author:HowarthPP, pubmed-author:KauffmannFF, pubmed-author:KowalskiM LML, pubmed-author:LenzenGG, pubmed-author:Lodrup-CarlsenKK, pubmed-author:LotvallJJ, pubmed-author:MullolJJ, pubmed-author:Nizankowska-MogilnickaEE, pubmed-author:PapadopoulosNN, pubmed-author:RadotEE, pubmed-author:RingJJ, pubmed-author:SalapatasMM, pubmed-author:SchünemannH JHJ, pubmed-author:SzczecklikAA, pubmed-author:Todo-BomAA, pubmed-author:ToskalaEE, pubmed-author:ValovirtaEE, pubmed-author:WickmanMM, pubmed-author:ZockJ PJP, pubmed-author:ZuberbierTT, pubmed-author:von MutiusEE
pubmed:issnType
Electronic
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
969-77
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
pubmed:affiliation
University Hospital and INSERM U780, Hôpital Arnaud de Villeneuve, Montpellier, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't